Literature DB >> 9810428

[Risk of transmission of Trypanosoma cruzi by blood transfusion in Mexico].

C Guzmán Bracho1, L García García, J Floriani Verdugo, S Guerrero Martínez, M Torres Cosme, C Ramírez Melgar, O Velasco Castrejón.   

Abstract

Data from the late eighties indicate that 1.6% of the Mexican population was infected with Chagas' disease and that transmission by way of blood transfusion was taking place in nearly every state, in areas of different sizes. The risk of transmission via that route has seldom been documented in Mexico, and for this reason a sentinel survey was conducted in 1994 in 18 blood banks belonging to the Ministry of Health and located in various states. The purpose of the study was to determine the risk of transmission via blood transfusion and to calculate the national prevalence of infection among potential donors, so as to have a set of general indicators of the prevailing disease burden and of the importance of this transmission route. Participants were selected on the basis of operating criteria: all government-run transfusion centers with the capacity to screen blood donors for at least one year and persons seeking to donate blood (n = 64,969) who satisfied the Official Mexican Standards (Norma Official Mexicana) for the therapeutic use of human blood and blood products. For the analysis of the results the centers were grouped according to migration flow in order to detect any possible influence the latter may have had on Chagas' disease transmission within the country. Screening was done with indirect hemagglutination using a reagent produced by the Instituto Nacional de Diagnóstico y Referencia Epidemiológicos and donated to the blood banks. Positive cases were confirmed by indirect immunofluorescence. Positive results were detected in 996 persons, for a prevalence of 1.5% (95% CI: 1.44 to 1.63). Concordance between the final results obtained by local labs and by the central lab was given by a kappa index of 0.87 (95% CI: 0.862 to 0.877). Cities having the highest emigration rates had three times the risk of transmission as compared to cities that drew immigrants (odds ratio = 2.82; 95% CI: 2.18 to 3.65). We recommend that mandatory serologic screening be enforced throughout Mexico, since migration makes it difficult to determine which areas are endemic.

Entities:  

Mesh:

Year:  1998        PMID: 9810428     DOI: 10.1590/s1020-49891998000800004

Source DB:  PubMed          Journal:  Rev Panam Salud Publica        ISSN: 1020-4989


  16 in total

1.  A Critical Assessment of Officially Reported Chagas Disease Surveillance Data in Mexico.

Authors:  Ellen M Shelly; Rodolfo Acuna-Soto; Kacey C Ernst; Charles R Sterling; Heidi E Brown
Journal:  Public Health Rep       Date:  2016 Jan-Feb       Impact factor: 2.792

Review 2.  Safety of the blood supply in Latin America.

Authors:  Gabriel A Schmunis; Jose R Cruz
Journal:  Clin Microbiol Rev       Date:  2005-01       Impact factor: 26.132

3.  Short report: Increasing access to treatment for Chagas disease: the case of Morelos, Mexico.

Authors:  Jennifer Manne-Goehler; Janine M Ramsey; Marco Ocampo Salgado; Veronika J Wirtz; Michael R Reich
Journal:  Am J Trop Med Hyg       Date:  2014-09-29       Impact factor: 2.345

4.  Human Trypanosoma cruzi infection and seropositivity in dogs, Mexico.

Authors:  Jose G Estrada-Franco; Vandanajay Bhatia; Hector Diaz-Albiter; Laucel Ochoa-Garcia; Alberto Barbabosa; Juan C Vazquez-Chagoyan; Miguel A Martinez-Perez; Carmen Guzman-Bracho; Nisha Garg
Journal:  Emerg Infect Dis       Date:  2006-04       Impact factor: 6.883

5.  Prevalence of antibody to Trypanosoma cruzi in Hispanic-surnamed patients seen at Parkland Health & Hospital System, Dallas, Texas.

Authors:  Roberto Arena; Christine E Mathews; Anne Y Kim; Tim E Lenz; Paul M Southern
Journal:  BMC Res Notes       Date:  2011-04-29

6.  Intrusive versus domiciliated triatomines and the challenge of adapting vector control practices against Chagas disease.

Authors:  Etienne Waleckx; Sébastien Gourbière; Eric Dumonteil
Journal:  Mem Inst Oswaldo Cruz       Date:  2015-03-14       Impact factor: 2.743

7.  Atlas of Mexican Triatominae (Reduviidae: Hemiptera) and vector transmission of Chagas disease.

Authors:  Janine M Ramsey; A Townsend Peterson; Oscar Carmona-Castro; David A Moo-Llanes; Yoshinori Nakazawa; Morgan Butrick; Ezequiel Tun-Ku; Keynes de la Cruz-Félix; Carlos N Ibarra-Cerdeña
Journal:  Mem Inst Oswaldo Cruz       Date:  2015-03-14       Impact factor: 2.743

8.  Opportunities for improved chagas disease vector control based on knowledge, attitudes and practices of communities in the yucatan peninsula, Mexico.

Authors:  Kathryn Rosecrans; Gabriela Cruz-Martin; Ashley King; Eric Dumonteil
Journal:  PLoS Negl Trop Dis       Date:  2014-03-27

9.  Barriers to treatment access for Chagas disease in Mexico.

Authors:  Jennifer M Manne; Callae S Snively; Janine M Ramsey; Marco Ocampo Salgado; Till Bärnighausen; Michael R Reich
Journal:  PLoS Negl Trop Dis       Date:  2013-10-17

10.  Opportunity cost for early treatment of Chagas disease in Mexico.

Authors:  Janine M Ramsey; Miguel Elizondo-Cano; Gilberto Sanchez-González; Adriana Peña-Nieves; Alejandro Figueroa-Lara
Journal:  PLoS Negl Trop Dis       Date:  2014-04-17
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.